Yunzhong Li

Title: Innovations of Yunzhong Li

Introduction

Yunzhong Li is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of NEP inhibitors. With a total of seven patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Yunzhong Li's latest patents include a process for early sacubitril intermediates. This invention relates to a new enantioselective process for producing useful intermediates for the manufacture of NEP inhibitors or prodrugs thereof. Specifically, it focuses on NEP inhibitors comprising a γ-amino-δ-biphenyl-α-methylalkanoic acid or acid ester backbone. Another notable patent is for the preparation of intermediates useful for the manufacture of NEP inhibitors. This invention also emphasizes a new process for producing useful intermediates, particularly those comprising a γ-amino-δ-biphenyl-α-methylalkanoic acid or acid ester backbone, such as N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester or salt thereof.

Career Highlights

Yunzhong Li is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in drug development. His expertise in the field has led to advancements that benefit both the company and the broader medical community.

Collaborations

Yunzhong Li has collaborated with notable colleagues, including David Hook and Jianguang Zhou. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Yunzhong Li's contributions to the field of pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science. His work continues to impact the development of important therapeutic agents.